Biotech Values

[DewDiligence]

Yes, of course Bischofberger is talking book. I nevertheless find his opinion noteworthy because it’s the strongest statement in favor of all-oral cures for HCV that I’ve heard from anyone of consequence in the industry. Moreover, I find it notable that Bischofberger thinks even three drugs may not be enough and a four-drug cocktail might be needed.

Note that the base post in this thread contained some questionable assertions by you and dewophile based on the failure of a two-drug oral regimen from BMY.